Global Benign Prostatic Hyperplasia Treatment Market Size, & Forecast 2019-2025Posted by nabeel on February 15th, 2021 The global benign prostatic hyperplasia treatment market is estimated to witness significant growth during the forecast period. The rising demand for innovative treatment options for benign prostatic hyperplasia is driving the market growth. 5 alpha-reductase inhibitors are the new innovation in benign prostatic hyperplasia drug treatment market. This helps to treat the lower urinary tract. further, artery embolization is the new innovation in minimally invasive procedure alternatives to surgery for benign prostatic hyperplasia treatment. This procedure is less costly and less painful, with no hospital stay. Transurethral resection of the prostate (TURP) is one of the innovation in the minimally invasive procedure, this was developed by the surgical urology team at Penn State Health Milton S. Hershey Medical Center. Rezum, a minimally invasive technology one of the innovations in this field for the treatment of benign prostatic hyperplasia. Rezum is used for prostate volumes greater than 30 cm3. To Request a Sample of our Report on Global Benign Prostatic Hyperplasia Treatment Market : https://www.omrglobal.com/request-sample/benign-prostatic-hyperplasia-treatment-market Due to the very low-risk rate, prostatic hyperplasia patients are moving towards laser therapy/surgeries. For patients with moderate or large prostates often prefer laser surgery. Some of the innovations in the laser surgeries are holmium and Photo selective Vaporization of the Prostate (PVP), Holmium Laser Enucleation of the Prostate (HoLEP), and others. Photo selective Vaporization of the Prostate (PVP) is also known as “Greenlight laser”. This is a minimally invasive technique, it uses high-powered laser light to vaporize the overgrowth of prostate cells. Holmium Laser Enucleation of the Prostate (HoLEP), this laser surgery used to remove the blockages of urine flow, this procedure is done without any cut in the body. Global Benign Prostatic Hyperplasia Treatment Market Segmentation Types of Treatment
o Alpha-blockers o 5 Alpha reductase inhibitor (ARIs) o Phosphodiesterase-5 Enzyme Inhibitor o Others
o Transurethral Resection of the Prostate (TURP) o Transurethral Incision of the Prostate (TUIP) o Transurethral Microwave Thermotherapy (TUMT) o Transurethral Needle Ablation (TUNA)
o Ablative procedures o Enucleation procedures
Global Benign Prostatic Hyperplasia Treatment Market – Segment by Region North America
Europe
Asia-Pacific
Rest of the World Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/benign-prostatic-hyperplasia-treatment-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404 Company Name: Orion Market Research Like it? Share it! More by this author |